This patient with clinical features of early-onset Parkinson’s disease was found to be compound heterozygous for SLC6A3 mutations (Ile312Phe, Asp421Asn) (Henriksen et al., 2012). This evidence concerns the gene SLC6A3 and Parkinson disease.